Bedel Financial Consulting, Inc. Merck & Co., Inc. Transaction History

Bedel Financial Consulting, Inc.

$716 Million
Q3 2024

A detailed history of Bedel Financial Consulting, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bedel Financial Consulting, Inc. holds 6,466 shares of MRK stock, worth $641,750. This represents 0.1% of its overall portfolio holdings.

Number of Shares

6,466

Previous 7,001 7.64%

Holding current value

$641,750

Previous $866,000 15.24%

% of portfolio

0.1%

Previous 0.13%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$111.15 - $128.97 $59,465 - $68,998	-535 Reduced 7.64%	6,466 $734,000
Q2 2024 Aug 05, 2024	BUY	$123.8 - $132.96 $91,735 - $98,523	741 Added 11.84%	7,001 $866,000
Q1 2024 May 07, 2024	SELL	$113.24 - $131.95 $9,059 - $10,556	-80 Reduced 1.26%	6,260 $826,000
Q4 2023 Feb 08, 2024	BUY	$100.18 - $109.02 $18,132 - $19,732	181 Added 2.94%	6,340 $691,000
Q3 2023 Feb 08, 2024	SELL	$102.95 - $114.33 $1,647 - $1,829	-16 Reduced 0.26%	6,159 $634,000
Q2 2023 Aug 10, 2023	BUY	$108.61 - $118.38 $5,864 - $6,392	54 Added 0.88%	6,175 $712,000
Q1 2023 May 02, 2023	SELL	$102.94 - $114.86 $27,690 - $30,897	-269 Reduced 4.21%	6,121 $651,000
Q4 2022 Feb 07, 2023	SELL	$87.44 - $112.11 $8,744 - $11,211	-100 Reduced 1.54%	6,390 $708,000
Q3 2022 Nov 08, 2022	SELL	$84.53 - $94.96 $22,823 - $25,639	-270 Reduced 3.99%	6,490 $649,000
Q2 2022 Aug 04, 2022	BUY	$83.49 - $94.64 $66,374 - $75,238	795 Added 13.33%	6,760 $616,000
Q2 2021 Aug 03, 2021	BUY	$70.31 - $77.77 $14,062 - $15,554	200 Added 3.47%	5,965 $464,000
Q1 2021 Apr 26, 2021	BUY	$68.86 - $81.11 $235,088 - $276,909	3,414 Added 145.21%	5,765 $444,000
Q3 2020 Oct 20, 2020	SELL	$73.18 - $82.95 $4,829 - $5,474	-66 Reduced 2.73%	2,351 $195,000
Q1 2020 May 06, 2020	BUY	$63.36 - $87.82 $3,611 - $5,005	57 Added 2.42%	2,417 $186,000
Q4 2019 Jan 28, 2020	BUY	$77.58 - $87.54 $3,103 - $3,501	40 Added 1.72%	2,360 $215,000
Q2 2019 Aug 01, 2019	BUY	$69.84 - $81.59 $69 - $81	1 Added 0.04%	2,320 $194,000
Q4 2018 Jan 28, 2019	SELL	$65.24 - $75.71 $13,047 - $15,141	-200 Reduced 7.94%	2,319 $177,000
Q3 2018 Nov 01, 2018	BUY	$57.69 - $67.84 $11,595 - $13,635	201 Added 8.67%	2,519 $179,000
Q2 2018 Jul 18, 2018	BUY	$50.83 - $59.72 $3,812 - $4,479	75 Added 3.34%	2,318 $141,000
Q1 2018 May 03, 2018	BUY	$50.96 - $59.23 $114,303 - $132,852	2,243 New	2,243 $122,000

Others Institutions Holding MRK

# of Institutions

3,829

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.

Account

Bedel Financial Consulting, Inc. Merck & Co., Inc. Transaction History